LPL and Alzheimer disease: LPL is a downstream target gene of lipid-activated transcription factor PPARγ, which has been reported to be implicated in the progression of AD (Medrano-Jiménez et al., 2019; Chamberlain et al., 2020; Kotha et al., 2020; Xie et al., 2020).